MF

Matthew Colin Thor Fyfe

RE Respivert: 9 patents #1 of 32Top 4%
TL Topivert Pharma Limited: 9 patents #1 of 21Top 5%
OS Oryzon Genomics S.A.: 3 patents #1 of 15Top 7%
📍 Church Hanborough, GB: #1 of 17 inventorsTop 6%
Overall (2017): #4,787 of 506,227Top 1%
12
Patents 2017

Issued Patents 2017

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
9850233 Kinase inhibitors 2017-12-26
9822076 Kinase inhibitor 2017-11-21
9796742 Kinase inhibitors Michael Knaggs, Premji Meghani, Stephen Malcolm Thom 2017-10-24
9790209 Kinase inhibitors Premji Meghani, Matthew Alexander Henry Stent, Stephen Malcolm Thom, Claire Walshe 2017-10-17
9783556 Kinase inhibitors Premji Meghani, Stephen Malcolm Thom 2017-10-10
9771353 Kinase inhibitors based upon N-alkyl pyrazoles 2017-09-26
9751837 Kinase inhibitors Thomas Matthew Baker, Geraint Jones, Stephen Malcolm Thom 2017-09-05
9732063 Kinase inhibitors Fritz-Frieder Frickel, Premji Meghani, Stephen Malcolm Thom 2017-08-15
9708309 Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use Alberto Ortega Muñoz, Marc Martinell Pedemonte, Inigo TIRAPU FERNANDEZ DE LA CUESTA, Maria de los Angeles Estiarte-Martinez 2017-07-18
9701670 Pyrazolyl-ureas as kinase inhibitors Claire Anne Marie Cariou, Catherine Elisabeth Charron, Euan Alexander Fraser Fordyce, Daniel Hamza, Kazuhiro Ito +6 more 2017-07-11
9676701 Cyclopropylamine derivatives useful as LSD1 inhibitors Alberto Ortega Muñoz, Julio Castro-Palomino Laria, Marc Martinell Pedemonte, Maria de los Angeles Estiarte-Martinez, Nuria Valls Vidal 2017-06-13
9670136 (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Alberto Ortega Muñoz, Marc Martinell Pedemonte, Maria de los Àngeles Estiarte Martinez, Nuria Valls Vidal, Guido Kurz +1 more 2017-06-06